Results 61 to 70 of about 9,378 (173)

Real‐world use of Cenobamate in pediatric drug‐resistant epilepsy: A European multicenter retrospective study

open access: yesEpilepsia Open, EarlyView.
Abstract Pediatric drug‐resistant epilepsy (DRE) remains a significant clinical challenge, with few effective pharmacological options. This European multicenter retrospective study assessed the real‐world efficacy, tolerability, and retention of off‐label cenobamate (CNB) in 108 children and adolescents with DRE (median age: 13.83 years, range 3.9–19.8)
Konstantin L. Makridis   +14 more
wiley   +1 more source

Evaluation of the Efficacy of Carbamazepine and Oxcarbazepine in Trigeminal Neuralgia

open access: yesIatreia
Introduction: Trigeminal neuralgia is characterized by the presence of sudden, intense and repetitive orofacial pain generated in one or more branches of the trigeminal nerve; carbamazepine and oxcarbazepine are the first-line drugs for its treatment ...
de la Cruz-Rodriguez, Ronald   +4 more
doaj   +1 more source

Bridging computational and clinical strategies for presurgical identification of epileptogenic networks

open access: yesEpilepsia Open, EarlyView.
Abstract Objective About one third of epilepsy patients are drug‐resistant. Resective epilepsy surgery remains a key treatment option but depends critically on accurate identification of the seizure onset zone (SOZ), which is still guided mainly by subjective visual inspection of electrophysiological signals.
Tena Dubcek   +5 more
wiley   +1 more source

Cognitive Function During Oxcarbazepine Treatment for Partial Seizures

open access: yesPediatric Neurology Briefs, 2006
The effect of oxcarbazepine compared to standard antiepileptic drug therapy (carbamazepine and valproate) on cognitive function in 112 children and adolescents (ages 6 to 16 years) with newly diagnosed partial seizures was investigated in a multicenter ...
J Gordon Millichap
doaj   +1 more source

Response to anti‐seizure medications in children carrying novel or previously reported HCN1 gene variants

open access: yesEpilepsia Open, EarlyView.
Abstract Objective Variants in the HCN1 gene cause a syndrome of childhood epilepsy and developmental disability with a broad phenotypic range. Many affected children manifest with early infantile epileptic encephalopathy (EIEE) and highly drug‐resistant epilepsy.
Marium N. Khan, Nicholas P. Poolos
wiley   +1 more source

Oxcarbazepine in Paroxysmal Dyskinesia

open access: yesPediatric Neurology Briefs, 2009
Four unrelated children (ages 8, 9, 16 and 17 years) with idiopathic paroxysmal kinesigenic dyskinesia responding to low dose oxcarbazepine are reported from the Department of Pediatric Neurology, Helen DeVos Children’s Hospital, Grand Rapids, MI.
J Gordon Millichap
doaj   +1 more source

Association of Vitamin D Deficiency with Antiepileptic Drugs in Patients with Epilepsy

open access: yesArchives of Epilepsy, 2020
Objectives:Long-term usage of antiepileptic drugs is associated with abnormal bone mineral metabolism, osteoporosis and an increased risk of fracture. The main mechanism seems to be focused on vitamin D deficiency that arises from antiepileptics.
Oya ÖZTÜRK   +4 more
doaj   +1 more source

Astrocyte subtype‐specific alterations in the dentate gyrus of individuals with mesial temporal lobe epilepsy

open access: yesEpilepsia Open, EarlyView.
Abstract Objective Epilepsy affects approximately 50 million people worldwide and, although primarily attributed to neuronal dysfunction, increasing evidence highlights a critical role of glial cells, particularly astrocytes, in the pathophysiological mechanisms.
Chiara Lötzsch   +5 more
wiley   +1 more source

The gut microbiome and drug‐resistant epilepsy: Microbiome–antiseizure medication interactions and implications for pharmacoresistance

open access: yesEpilepsia Open, EarlyView.
Abstract Drug‐resistant epilepsy (DRE) affects approximately one‐third of patients with epilepsy and represents a major unmet clinical need. While traditional hypotheses of pharmacoresistance have focused on alterations in drug targets, efflux transporter overexpression, and intrinsic disease severity, the gut microbiome has recently emerged as a ...
Khaled Zammar   +4 more
wiley   +1 more source

Patch Testing in Paediatric Drug Hypersensitivity Reactions: Current Evidence and Clinical Implications

open access: yesContact Dermatitis, EarlyView.
ABSTRACT Drug hypersensitivity reactions (DHRs) are common in children and are diagnostically challenging, with cutaneous manifestations being the most common presentation. Patch testing (PT) is a well‐established tool for investigating delayed T‐cell‐mediated reactions and is widely used in patients with contact dermatitis.
Gabriele Simonetti   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy